Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Clinical trial NCT01915303 · TERMINATED
Trial details
- NCT number
- NCT01915303
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-06
- Primary completion
- 2016-09-05
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.